This study's aim is to evaluate the feasibility of introducing a women's malignancy survivorship clinic incorporating symptom management through ePRO collection (complex intervention) into routine follow up care in patients with early-stage Hormone Receptor(HR)-positive breast and gynaecologic cancer post primary curative therapy.
Age range
18 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Number of patients enrolled in the clinic.
Timeframe: At the baseline
Reasons for not enrolling to the study.
Timeframe: At the baseline
Reasons for not completing the intervention (drop out).
Timeframe: During the study period (12-month)
Percentage of adherence to the intervention completing ePROs surveys
Timeframe: Baseline, each 2 months till end intervention (12 months)
Number of patients who partake in healthcare professional consultations after ePRO data triggers.
Timeframe: Baseline, each 2 months till end intervention (12 months)
Average consultation time in the Womens Survivorship Clinic.
Timeframe: Baseline, each 2 months till end intervention (12 months)